Search for: "Apotex" Results 461 - 480 of 1,051
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2014, 2:01 am by Lawrence B. Ebert
Apotex involving the Pfizer’s patenting of the besylate form of amlodipine (salt form) which Apotex claimed was obvious in the light of Pfizer’s own patent on the base compound amlodipine.16 The CAFC, in agreeing with Apotex that the patent on the besylate form was invalid, highlighted the besylate form lacked the unexpected superior results from the base compound in order for the salt form to be patented.17 Indeed, the Manual for Patent Examination Procedure… [read post]
13 Mar 2016, 4:01 am by Administrator
Apotex Inc., Apotex Pharmachem Inc., 2015 FCA 158 (36654) How is patent invalidity for ‘inutility’ to be interpreted (in this sealing-order case). [read post]
10 Apr 2008, 9:45 am
Apotex Inc., ___ F.3d ___, 2008 WL 927848 (3d Cir. [read post]
13 Jun 2007, 6:57 am
We previously mentioned here that oral argument had been scheduled for Colacicco/McNellis for September 17, 2007. [read post]
9 Jul 2015, 4:01 am by Paula Bremner
Apotex intends to argue this technical issue as a summary judgment motion. [read post]
21 Jun 2012, 10:00 pm by Stephanie Figueroa
District Court for the District of New Jersey's ruling against Merck on the issue of patent infringement in its suit against Apotex Inc. and Apotex Corp. [read post]
21 Jun 2012, 10:00 pm by Stephanie Figueroa
District Court for the District of New Jersey's ruling against Merck on the issue of patent infringement in its suit against Apotex Inc. and Apotex Corp. [read post]
17 Oct 2008, 1:32 pm
Proposed EU information laws on prescription drugs (IPmed) Iceland: Supplementary Protection Certificates (SPCs) in Iceland (The SPC blog) India: Roche implements 'mass serialisation' anti-counterfeiting technology (Spicy IP) Indonesia: Patent application on oil palm hybrids (navigating the patent maze) United States: New PMCA research: State legislative proposals restricting access to generic medicines would increase cost $29 billion over 10 years (GenericsWeb) US: Pharmaceutical… [read post]
25 Jul 2013, 11:43 am by Dennis Crouch
In 2010, GSK began manufacturing its own generic version that was distributed and sold by Apotex. [read post]
25 Apr 2010, 5:52 pm by FDABlog HPM
  The FTC charged that, among other things, BMS failed to disclose (as part of a patent settlement with Apotex) that the company orally promised that it would not compete with Apotex during the first 180-days that Apotex marketed its generic version of PLAVIX. [read post]
3 Nov 2010, 1:21 am by Kelly
General Bell tolls for biodiversity benefit-sharing treaty (IP Watch) Ministers arrive to help reach outcome at UN convention on biodiversity (IP Watch) Delegates see UN protocol against biopiracy within reach (IP Watch) Pfizer and Biocon sign global commercialisation agreement on biosimilars (Patent Docs) Brazil: Paragraph 6 system: Brazilian intervention at the WTO TRIPS Council (KEI) Canada’s intervention to TRIPS Council: Experience using the System (Apotex-Rwanda Case) (KEI)… [read post]
12 Dec 2008, 8:42 am
Apotex argues that the presumption should be particularly strong here, because the prior art patents belong to Sanofi. [read post]
29 Jan 2014, 9:12 pm by Lawrence B. Ebert
Apotex, Inc., 480 F.3d 1348, 1372 (Fed. [read post]
6 Sep 2015, 12:30 am by Mark Summerfield
Last week I predicted that the High Court would affirm the finding of five judges of the Federal Court of Australia that AstraZenenca’s patents covering low-dosage forms of the cholesterol-lowering drug marketed as CRESTOR (having the active ingredient rosuvastatin) are invalid on grounds of obviousness.In the much-anticipated decision in AstraZeneca AB v Apotex Pty Ltd (et al) [2015] HCA 30, five judges of the High Court, in four distinct concurring opinions, have unanimously… [read post]
1 Apr 2014, 6:11 am by Lawrence B. Ebert
Apotex The outcome was that Senju's claims were barred by claim preclusion. [read post]